Key Metrics
CiteScore 

5.8
Impact Factor 

< 5
SJR 

Q2Oncology

SNIP 

1.35
Recommended pre-submission checks
Powered by 

Topics Covered on Hematology/Oncology Clinics of North America
Hematology/Oncology Clinics of North America Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
SJR
| Overview | |
| Publisher | W B SAUNDERS CO-ELSEVIER INC |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1987 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Hematology/Oncology Clinics of North America ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Hematology/Oncology Clinics of North America
Early-Stage Hodgkin Lymphoma: Time for Novel Agents?
- 1 Apr 2026
- Hematology/oncology clinics of North America
Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies.
- 1 Apr 2026
- Hematology/oncology clinics of North America
Contents
- 1 Apr 2026
- Hematology/Oncology Clinics of North America
Contributors
- 1 Apr 2026
- Hematology/Oncology Clinics of North America
New Tools and Drugs Improve the Balance Between Cure and Toxicity in Hodgkin Lymphoma.
- 1 Apr 2026
- Hematology/oncology clinics of North America
New Standards in Advanced-stage Hodgkin Lymphoma: Selecting a Novel Regimen.
- 1 Apr 2026
- Hematology/oncology clinics of North America
Early-Stage Hodgkin Lymphoma: Time for Novel Agents?
- 1 Apr 2026
- Hematology/oncology clinics of North America
Selection of a Salvage Regimen for Relapsed or Refractory Classic Hodgkin Lymphoma in the Era of Novel Therapies.
- 1 Apr 2026
- Hematology/oncology clinics of North America
Contents
- 1 Apr 2026
- Hematology/Oncology Clinics of North America
Contributors
- 1 Apr 2026
- Hematology/Oncology Clinics of North America
New Tools and Drugs Improve the Balance Between Cure and Toxicity in Hodgkin Lymphoma.
- 1 Apr 2026
- Hematology/oncology clinics of North America
New Standards in Advanced-stage Hodgkin Lymphoma: Selecting a Novel Regimen.
- 1 Apr 2026
- Hematology/oncology clinics of North America